PL2324824T3 - Medyczne zastosowanie lipidowych pochodnych dopaminy - Google Patents

Medyczne zastosowanie lipidowych pochodnych dopaminy

Info

Publication number
PL2324824T3
PL2324824T3 PL10191670T PL10191670T PL2324824T3 PL 2324824 T3 PL2324824 T3 PL 2324824T3 PL 10191670 T PL10191670 T PL 10191670T PL 10191670 T PL10191670 T PL 10191670T PL 2324824 T3 PL2324824 T3 PL 2324824T3
Authority
PL
Poland
Prior art keywords
dopamine
medical application
lipid derivative
lipid
derivative
Prior art date
Application number
PL10191670T
Other languages
English (en)
Inventor
Mieczysław Pokorski
Agnieszka Rękawek
Dominika Zając
Zbigniew Czarnocki
Edmund Przegaliński
Jolanta Konieczny
Piotr Roszkowski
Original Assignee
Inst Medycyny Doswiadczalnej I Klinicznej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medycyny Doswiadczalnej I Klinicznej filed Critical Inst Medycyny Doswiadczalnej I Klinicznej
Publication of PL2324824T3 publication Critical patent/PL2324824T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10191670T 2009-11-19 2010-11-18 Medyczne zastosowanie lipidowych pochodnych dopaminy PL2324824T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL389621A PL389621A1 (pl) 2009-11-19 2009-11-19 Nowe zastosowanie medyczne lipidowych pochodnych dopaminy oraz sposób ich wytwarzania
EP10191670.8A EP2324824B1 (en) 2009-11-19 2010-11-18 Medical application of a lipid derivative of dopamine

Publications (1)

Publication Number Publication Date
PL2324824T3 true PL2324824T3 (pl) 2014-11-28

Family

ID=43402179

Family Applications (2)

Application Number Title Priority Date Filing Date
PL389621A PL389621A1 (pl) 2009-11-19 2009-11-19 Nowe zastosowanie medyczne lipidowych pochodnych dopaminy oraz sposób ich wytwarzania
PL10191670T PL2324824T3 (pl) 2009-11-19 2010-11-18 Medyczne zastosowanie lipidowych pochodnych dopaminy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL389621A PL389621A1 (pl) 2009-11-19 2009-11-19 Nowe zastosowanie medyczne lipidowych pochodnych dopaminy oraz sposób ich wytwarzania

Country Status (3)

Country Link
EP (1) EP2324824B1 (pl)
PL (2) PL389621A1 (pl)
SI (1) SI2324824T1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697898B2 (en) 2011-11-23 2014-04-15 Instytut Medycyny Doswiadczalnej i Klinicznej im. M. Mossakowskiego PAN Medical application of lipid derivatives of dopamine and the methods of their production
CN119235833B (zh) * 2024-08-30 2025-10-24 暨南大学 N-酰基多巴胺家族脂质在防治药物诱导的帕金森病运动并发症中的应用

Also Published As

Publication number Publication date
EP2324824A2 (en) 2011-05-25
EP2324824B1 (en) 2014-06-18
PL389621A1 (pl) 2011-05-23
EP2324824A3 (en) 2011-06-15
SI2324824T1 (sl) 2014-10-30

Similar Documents

Publication Publication Date Title
AP3774A (en) A novel formulation of diclofenac
EP2339918A4 (en) PREPARATION OF A QUINOLINYLOXYDIPHENYLCYCLOPROPANEDICARBOXAMIDE
EP2632360A4 (en) IMPROVED ASSISTED BY BIO-IMPEDANCE OF A MEDICAL DEVICE
AP3628A (en) A novel formulation of indomethacin
AP3659A (en) A novel formulation of meloxicam
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
EP2420244A4 (en) MEANS TO PROMOTE FATTY CHANGE
EP2413177A4 (en) CAPSULE ENDOSCOPE
GB201016832D0 (en) Garment technology for application of therapeutic pressure
IL213354A0 (en) Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
ZA201105779B (en) Benzothiazolone derivative
ZA201200751B (en) Fluorinated derivatives of 3-hydroxypyridin-4-ones
SI2324824T1 (sl) Medicinska uporaba lipidnega derivata dopamina
IL245577A0 (en) Dose unit of efdanosone
GB0813347D0 (en) A set of parts
ZA201107542B (en) Compounds having a physiological effect
IL220059A0 (en) Combretastatin derivative preparation method
IL257014A (en) A novel formulation of meloxicam
GB0904499D0 (en) A set of parts
PL386302A1 (pl) Nowa pochodna izotiazolopirydyny
GB0919237D0 (en) Improvements of a device
AU2009901742A0 (en) A Novel Formulation of Meloxicam
PL118446U1 (pl) Obudowa czujnika zbliżeniowego